30. Employee Participation Plans
Audited information- Index
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
Under the Group Senior Management – Long-Term Incentive Plan (GSM-LTIP) a certain percentage of the actual bonus is granted to the plan participants in the form of registered shares of Clariant Ltd (investment shares). These shares vest immediately upon grant, but are subject to a three-year blocking period. The plan participants receive an additional share free of cost (matching share) for each investment share held at the end of the blocking period.
These shares were granted for the first time in 2011, based on the performance achieved in the base year 2010. Similar plans were launched in all subsequent years. The number of shares not yet vested and thus disclosed are the matching shares already granted.
For the first time in 2013, the Performance Share Unit (PSU) Plan was introduced for all senior managers to replace the former Tradable Option Plan. The term of Clariant’s Performance Share Unit Plan is a three-year vesting period. The vesting is conditional upon achievement of the performance targets at the end of the vesting period. If the performance targets are achieved, each PSU will be converted into one Clariant share.
A new grant took place in September 2018. The review of the target achievements (vesting criteria) for this plan will be held in summer 2021 and vesting is scheduled to take place in September 2021.
The expense recorded in the income statement spreads the costs of each grant over the measurement period and the vesting period. Assumptions are made concerning the forfeiture rate which is adjusted during the vesting period so that at the end of the vesting period there is only a charge for the vested amounts.
In 2018, CHF 3 million were credited to the income statement for equity-settled share-based payments (2017: expense of CHF 9 million). Some accruals in equity for share based payments were reversed, as the key performance indicators were not met.
As of 31 December 2018, the total carrying value of liabilities arising from equity-settled share-based payments, entirely recognized in equity, is CHF 14 million (2017: CHF 25 million).
As per 31 December 2017 and 2018, no further options were outstanding for members of the management and the executive committee.
Base year |
Granted |
Vesting in |
|
Share price at grant date |
Number 31.12.2018 |
Number 31.12.2017 |
||||||
2014 |
2015 |
2018 |
|
19.71 |
— |
171 123 |
||||||
2015 |
2015 |
2018 |
|
19.70 |
— |
5 000 |
||||||
2015 |
2015 |
2018 |
|
17.39 |
— |
13 813 |
||||||
2015 |
2015 |
2018 |
|
19.10 |
— |
409 521 |
||||||
2015 |
2016 |
2019 |
|
16.98 |
192 237 |
227 725 |
||||||
2016 |
2016 |
2019 |
|
16.84 |
469 603 |
533 997 |
||||||
2016 |
2016 |
2019 |
|
16.87 |
5 000 |
5 000 |
||||||
2016 |
2017 |
2020 |
|
18.67 |
186 293 |
230 379 |
||||||
2017 |
2017 |
2020 |
|
22.11 |
376 974 |
432 613 |
||||||
2017 |
2017 |
2020 |
|
18.74 |
12 831 |
12 831 |
||||||
2017 |
2017 |
2020 |
|
19.15 |
11 799 |
11 799 |
||||||
2017 |
2018 |
2021 |
|
22.82 |
136 409 |
— |
||||||
2018 |
2018 |
2021 |
|
23.58 |
369 349 |
— |
||||||
2018 |
2018 |
2021 |
|
21.47 |
3 960 |
— |
||||||
2018 |
2018 |
2021 |
|
24.11 |
2 074 |
— |
||||||
2018 |
2018 |
2022 |
|
20.38 |
8 587 |
— |
||||||
2018 |
2018 |
2020 |
|
20.38 |
8 587 |
|
||||||
Total |
|
|
|
|
1 783 703 |
2 053 801 |
|
Weighted average exercise price |
Shares 2018 |
Weighted average exercise price |
Options 2017 |
Shares 2017 |
|||||||
|
||||||||||||
Shares/options outstanding at 1 January |
16.50 |
2 053 801 |
16.50 |
660 243 |
2 173 777 |
|||||||
Granted |
|
801 436 |
|
— |
996 690 |
|||||||
Exercised/distributed* |
|
–390 915 |
18.67 |
–646 843 |
–516 649 |
|||||||
Cancelled/forfeited |
|
–680 619 |
|
–13 400 |
–600 017 |
|||||||
Outstanding at 31 December |
18.09 |
1 783 703 |
16.50 |
— |
2 053 801 |
|||||||
Exercisable at 31 December |
|
|
|
|
|
|||||||
Fair value of shares/options outstanding in CHF |
|
32 267 178 |
|
|
55 966 064 |
* Options exercised in 2017 included 355 800 options pertaining to the 2011 and 2012 option plans, which were sold by the plan participants in the market. In the meantime all option plans have expired.
The fair value of shares granted during 2018 is CHF 10 million (2017: CHF 20 million) calculated based on market value of shares at grant date.
No options were granted in 2018 and 2017.